Recent updates on the resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors and resistance reversion strategies in lung cancer-Reference-Cited by-同舟云学术

Recent updates on the resistance mechanisms to epidermal growth factor receptor tyrosine kinase inhibitors and resistance reversion strategies in lung cancer

Published:2020-06-29 Issue:6 Volume:40 Page:2132-2176
ISSN:0198-6325
Container-title:Medicinal Research Reviews
language:en
Short-container-title:Med Res Rev

Author:

Tripathi Surya K.¹^ORCID,Pandey Kamal¹,Rengasamy Kannan R. R.²^ORCID,Biswal Bijesh K.¹^ORCID

Affiliation:

1. Cancer Drug Resistance Laboratory, Department of Life Science National Institute of Technology Rourkela Rourkela India

2. Department of Bioresources and Food Science Konkuk University Seoul South Korea

Funder

Department of Science and Technology, Odisha, India

Department of Science and Technology, Science and Engineering Research Board (DST, SERB), New Delhi, India

Publisher

Wiley

Subject

Drug Discovery,Pharmacology,Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/med.21700

Reference247 articles.

1. Cancer treatment and survivorship statistics, 2016

2. Lung Cancers: Molecular Characterization, Clonal Heterogeneity and Evolution, and Cancer Stem Cells

3. Molecular heterogeneity in lung cancer: from mechanisms of origin to clinical implications

4. EGFR genetic heterogeneity of nonsmall cell lung cancers contributing to acquired gefitinib resistance

5. EGFR Mutations and Lung Cancer

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel benzenesulfonamides as dual VEGFR2/FGFR1 inhibitors targeting breast cancer: Design, synthesis, anticancer activity and in silico studies;Bioorganic Chemistry;2024-11

2. Appropriate delay of primary tumour radiotherapy may lead to better long-term overall survival for non-small cell lung cancer treated with EGFR-TKIs;BMC Cancer;2024-08-26

3. Promoting reactive oxygen species accumulation to overcome tyrosine kinase inhibitor resistance in cancer;Cancer Cell International;2024-07-09

4. MRI radiomics predicts the efficacy of EGFR-TKI in EGFR-mutant non-small-cell lung cancer with brain metastasis;Clinical Radiology;2024-07

5. New Theobromine Apoptotic Analogue with Anticancer Potential Targeting the EGFR Protein: Computational and In Vitro Studies;ACS Omega;2024-03-27